Xifaxan / Salix Pharmaceuticals / OHE / DTC
Xifaxan OHE Campaign
Prescription DrugDTCRotoscoping
Xifaxan / Salix Pharmaceuticals / OHE / DTC
Overview
A DTC campaign for Xifaxan (rifaximin), the first and only FDA-approved treatment for reducing the risk of overt hepatic encephalopathy recurrence in adults. LOBO brought the patient’s cognitive fog to life through a seamless blend of live action and painterly illustration, making a complex neurological complication feel visceral and emotionally real for patients and caregivers alike.
Credits
Agency
Syneos Health PR
Executive creative director
John Reid
Group creative director and copy
Steffany Carey
Associate creative director and art
Jeff Abelson
Agency producer
Karen Fazekas
Creative director
Mateus de Paula Santos
Directors
Mateus de Paula Santos
Ricardo Carelli
Live action director
Ricardo Carelli
Director of photography
Rod Hauer
Managing partner
Luis Ribeiro
Executive producer
Su Constantine
Head of production
Marcelo Barbosa
Head of post production
Eduardo Silva
Producer
Pablo Zurita
Line producer and 1st AD
Tom Martin
João Maurício Leonel
Production designer
David Hedge
Post-production coordinator
Rosângela Gomes
Nathaly Lopes
Post-production producer
Rafael Bozzi
Editor
Pedro Falcone
Concept art
Rafael Fernandes
Marco Furtado
Storyboard
Fernando Heynen
Compositing
Narayani Andrade
Paulo Quinhone
Marcos Rigobello
Motion graphics
Felipe Silva
CG coordinator
Marisa Ditleff
Modeling
Natan Ernani
2D animation
Gorila Studio
Colour grading
Royal Muster, New York
Music
Future Perfect and Sound Goods
Ingest, conform and delivery
Isabela Balbo
Marco Tavares
Fábio Augusto
More work
